SCERG Banner

Focus Area Devices and Materials Engineering for Sustainability and Health (dMESH)

Sustainable Tissue Engineering, Materials and Processes (STEM-P)

PI: Frederico Ferreira

STEM-P laboratory mission is to foster research on materials science and processes design to improve sustainability and well-being, on interaction with animal cell-based technologies.

STEM-P provides continuous innovation on novel materials, tissue engineering approaches, novel devices and bioreactors, and manufacturing process design.

1. IMPACT: STEM-P aims to impact on two very different fields:

  • Tissue engineering and cancer therapies, focused on the developing of novel biomimetic and bioinspired materials and bioreactors for tissue engineering -including electrical, piezoelectrical and magnetic stimuli responsive nanotechnologies, scaffolds and bioinks- for developing tissue constructs from stem cells and target cancer therapies that explore biophysical approaches; and
  • Cellular agriculture, with focus on fish-based food products manufactured with low ecological impact, namely by developing novel edible bio-inks and scaffolds made from algae and vegan materials and their use on strategies that foster tissue growth, maturation and organisation into final food prototypes.

2. ENGINEER’S TOOLBOX: STEM-P develops innovative specific key enabling technologies and processes, working in close synergies with the other laboratories of dMESH, pMESH and SCERG namely:

a. Manufacture of functional advanced materials

  • Synthesis, functionalization and composite preparation of materials able to provide biological and physical cues, along with stimuli responsive properties, namely to electric, piezoelectric, magnetic, near infrared or ultrasounds as means to provide wireless stimulation.
  • Develop hybrid materials, combining synthetic and natural sustainable materials, for cell and organ engineering with adequate mechanic features (i.e. low stiffness, flexible or elastic), biodegradability, biocompatibility (including ability to modulate stem cell behaviour), facilitated cross-link and, importantly, being possible to be processed alone or with cells and extracellular matrices on 3D structures.
  • Formulate materials composites for use in hierarchical organization and mediation of stimuli delivery, combining stimuli responsive properties.

b. Manufacture of 3D scaffolds, electropun fibres and bioprinting for tissue constructs engineering

  • Design and construction of scaffolds and/or 3D direct printing of cells allows, respectively for top-down and bottom-up approaches, to support 3D culture of stem cells and tissue construct development.
  • Engineering different structures ranging from the nanoscale (nanoparticles, electrospun nanofibers) to macroscale (using additive manufacture techniques) using the functional materials developed, along with existing biomaterials and natural extracellular matrix components.
  • Develop novel approaches to foster hierarchical cell organization, support control drug/factor delivery and provide physical stimuli to cells, contributing to stem cell differentiation and maturation on tissue constructs.

c. Bioreactor, device and bioprinting designs and prototyping for 3D cell culture and processing

  • Design novel bioreactors and devices to support integration of cells, scaffolds and controlled physical stimuli, able to support and stimulate cell and tissue construct development.
  • Development of novel bioprinters able to assist novel approaches of tissue construct, namely combination of manufacturing techniques and cry-bioprinting.
  • Combining adequate mathematical models of mass transfer, mechanical forces distribution, shear stress, electrical and/or magnetic field intensities to design the scaffold and bioreactors and/or devices to support 3D cell culture and processing.

3. RESEARCH CHALLENGES: STEM-P conducts activities balance between fundamental and applied research to answer to specific research and technological questions, namely:

a. The effect of electrical and magnetic stimulation on cells

To investigate the effect of electrical, ultrasounds, and magnetic stimulation of stem cells, progenitor cells and cancer cells. Specifically, investigations have been focused on:

  • Electrical and piezoelectrical stimulation of iPSCs and progenitor cells for their differentiation and maturation aiming at the regeneration and development of different tissues, including neural and cardiac human tissue as well as fish muscle;
  • Magnetic stimulation of stem and progenitor cell-seeded scaffolds to tune cell secretome, enhancing its angiogenic potential and production of viable tissues, as well as use electromagnetic fields and responsive biomaterial platforms for manufacture of 3D tissue constructs; and
  • Electrical and piezoelectrical stimulation of cancer cells alone or including stimuli responsive nanoparticle systems are explored aiming to provide new cancer therapies (under leadership from Bioelectronics for Cancer Therapies lab at dMESH and Nanomaterials for Bioeconomy lab at pMESH).

b. Novel approaches to de develop biomimetic 3D sustainable tissues

  • Design and prototype fish fillets combining 3D bioprinting of fat and muscle bioinks with myo-septum electrospun fibers meshes and the use of electrical stimulation to enhance muscle maturation.
  • Develop novel elastic patches for superior cardiac, skin and neural tissue regeneration, comprising stimuli responsive materials allowing virtuous cycles between cells and materials.
  • Hierarchical scaffolds with electrical and piezoelectrical gradient for production of different tissue substitutes, including osteochondral tissues (under leadership from Biomimetic and Functional Regenerative Biomaterials lab at dMESH).

c. Economic assessment of innovative advanced therapies

Early economic assessment of advanced therapy medicinal products, medical technologies and advanced food production systems are essential to support decisions on the development of technologies, in close collaboration with clinicians and industrial partners (under collaboration with Bioreactor and Biomaterial Technologies for Stem Cell Manufacturing Lab at dMESH).

PhD students: Abdul Mateen, Afonso Gusmão, Ana Agostinho, Catarina Jones, Carlos Moreira, Diana Marques, Diogo Dias, Duarte Almeida, Frederico Barbosa, Filipe Miguel, Gonçalo Fernando, Joana Almeida, Kaue Morcelles, Kristin Schüler, Laura Alves, Laura Sordini, Leonor Resina, Miguel Nascimento, Nuno Luis, Pedro Marcelino, Rafaela Neves

Key collaborators

Robert J. Linhardt (Rensselaer Polytechnic Institute (RPI)), Jorge Morgado (Instituto de Telecomunicações), Carla Portugal (REQUIMTE/NOVA), Paula Faria (IPLeiria), Carlos Alemán (Universitat Politècnica de Catalunya), Stan Finkelstein (MIT), Frankie Rawson (University of Nottingham), Miguel Rodrigues (SmartFreez), Eduardo Pires (Bioceramed), Nuno Ribeiro (Hospital Luz)